JP2006502086A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006502086A5 JP2006502086A5 JP2003559480A JP2003559480A JP2006502086A5 JP 2006502086 A5 JP2006502086 A5 JP 2006502086A5 JP 2003559480 A JP2003559480 A JP 2003559480A JP 2003559480 A JP2003559480 A JP 2003559480A JP 2006502086 A5 JP2006502086 A5 JP 2006502086A5
- Authority
- JP
- Japan
- Prior art keywords
- carbons
- amino acid
- branched
- hydrogen
- linear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000000539 amino acid group Chemical group 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000008249 pharmaceutical aerosol Substances 0.000 claims description 5
- 239000003380 propellant Substances 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 150000001261 hydroxy acids Chemical class 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 239000012752 auxiliary agent Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims 4
- 235000001014 amino acid Nutrition 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical group C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 claims 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- 108010077895 Sarcosine Proteins 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 239000008365 aqueous carrier Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 claims 1
- 229940043230 sarcosine Drugs 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 229960003080 taurine Drugs 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34278701P | 2001-12-21 | 2001-12-21 | |
| US60/342,787 | 2001-12-21 | ||
| PCT/US2002/041299 WO2003059317A2 (en) | 2001-12-21 | 2002-12-20 | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006502086A JP2006502086A (ja) | 2006-01-19 |
| JP2006502086A5 true JP2006502086A5 (https=) | 2006-03-02 |
| JP4959919B2 JP4959919B2 (ja) | 2012-06-27 |
Family
ID=23343270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003559480A Expired - Fee Related JP4959919B2 (ja) | 2001-12-21 | 2002-12-20 | 官能基を有するポリエチレングリコール賦形剤を用いた医薬用エアロゾル組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7718162B2 (https=) |
| EP (1) | EP1458357B1 (https=) |
| JP (1) | JP4959919B2 (https=) |
| AT (1) | ATE424186T1 (https=) |
| AU (1) | AU2002367032B8 (https=) |
| CA (1) | CA2470520A1 (https=) |
| DE (1) | DE60231428D1 (https=) |
| WO (1) | WO2003059317A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2470520A1 (en) | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| JP2005514440A (ja) * | 2001-12-21 | 2005-05-19 | スリーエム イノベイティブ プロパティズ カンパニー | アミドおよび／またはエステルを含有する、賦形剤化合物を含む、医用エアロゾル組成物 |
| JP2005514437A (ja) * | 2001-12-21 | 2005-05-19 | スリーエム イノベイティブ プロパティズ カンパニー | イオン対複合体を含む医薬用エアロゾル製剤 |
| GB0614621D0 (en) | 2006-07-24 | 2006-08-30 | 3M Innovative Properties Co | Metered dose dispensers |
| GB0620700D0 (en) | 2006-10-19 | 2006-11-29 | 3M Innovative Properties Co | Metered dose valves and dispensers |
| DK2480197T3 (en) | 2009-09-25 | 2016-01-25 | Reddys Lab Ltd Dr | Compositions containing triptanforbindelser |
| US11337962B2 (en) | 2009-09-25 | 2022-05-24 | Upsher-Smith Laboratories, Llc | Formulations comprising triptan compounds |
| EP3020393B1 (en) | 2009-12-16 | 2020-10-07 | 3M Innovative Properties Company | Formulations and methods for controlling mdi particle size delivery |
| GB201118188D0 (en) | 2011-10-21 | 2011-12-07 | 3M Innovative Properties Co | Manufacture of medicinal aerosol canisters |
| GB201210580D0 (en) | 2012-06-14 | 2012-08-01 | 3M Innovative Properties Co | Metered dose dispensing valve |
| GB201221063D0 (en) | 2012-11-23 | 2013-01-09 | 3M Innovative Properties Co | Metered dose dispensing valve |
| US11981619B2 (en) | 2017-07-07 | 2024-05-14 | Basf Se | Alkoxylated esteramines and salts thereof |
| JP7657496B2 (ja) * | 2021-12-02 | 2025-04-07 | レジェロン，インコーポレイテッド | 多機能用途を有する天然賦形剤およびその調製プロセス |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1163028B (de) * | 1960-03-09 | 1964-02-13 | Hoechst Ag | Verfahren zur Polymerisation von Vinylchlorid |
| JPS63503304A (ja) | 1986-03-10 | 1988-12-02 | ブルグハルト，クルト | 医薬製剤およびその製造方法 |
| AU601176B2 (en) | 1986-03-10 | 1990-09-06 | Kurt Burghart | Benzodiazepine aerosols |
| US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| US5342940A (en) * | 1989-05-27 | 1994-08-30 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, process for preparing the same |
| WO1992000061A1 (en) | 1990-06-29 | 1992-01-09 | Fisons Plc | Pressurised aerosol compositions |
| AU5171293A (en) | 1992-10-14 | 1994-05-09 | Regents Of The University Of Colorado, The | Ion-pairing of drugs for improved efficacy and delivery |
| ATE177941T1 (de) | 1992-12-09 | 1999-04-15 | Boehringer Ingelheim Pharma | Stabilisierte medizinische aerosollösungen |
| ES2122261T3 (es) | 1993-03-17 | 1998-12-16 | Minnesota Mining & Mfg | Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester. |
| ES2107203T3 (es) | 1993-03-17 | 1997-11-16 | Minnesota Mining & Mfg | Una formulacion de aerosol que contiene un adyuvante de dispersion derivado de un diol-diacido. |
| US5492688A (en) | 1993-04-28 | 1996-02-20 | The Center For Innovative Technology | Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
| JPH09506097A (ja) | 1993-12-02 | 1997-06-17 | アボツト・ラボラトリーズ | 非ｃｆｃ噴射剤と共に用いるエアロゾル薬物調剤 |
| US5508023A (en) * | 1994-04-11 | 1996-04-16 | The Center For Innovative Technology | Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
| US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| ZA9711732B (en) * | 1996-12-31 | 1998-12-28 | Quadrant Holdings Cambridge | Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery |
| US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| US6218353B1 (en) | 1997-08-27 | 2001-04-17 | Micell Technologies, Inc. | Solid particulate propellant systems and aerosol containers employing the same |
| US6136294C1 (en) | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
| BR9914799A (pt) | 1998-10-27 | 2001-07-10 | Alcon Lab Inc | Sistema conservante para composições farmacêuticas administráveis topicamente contendo um sabão de ácido graxo/aminoácido |
| US6258857B1 (en) | 1999-02-04 | 2001-07-10 | Kyowa Industrial Co., Ltd. | Internal liquid composition contained as internal liquid in a releasing container and releasing container product |
| GB0016876D0 (en) | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Novel formulation |
| US7217409B2 (en) | 2000-09-22 | 2007-05-15 | Smithkline Beecham Corporation | Alkanoic acid derivatives |
| CZ20033182A3 (cs) | 2001-05-21 | 2004-09-15 | Nektar Therapeutics | Inzulínový prostředek a způsob podávání inzulínu |
| GB0125127D0 (en) | 2001-10-19 | 2001-12-12 | Glaxo Group Ltd | Compounds |
| JP2005514440A (ja) | 2001-12-21 | 2005-05-19 | スリーエム イノベイティブ プロパティズ カンパニー | アミドおよび／またはエステルを含有する、賦形剤化合物を含む、医用エアロゾル組成物 |
| CA2470520A1 (en) | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
-
2002
- 2002-12-20 CA CA002470520A patent/CA2470520A1/en not_active Abandoned
- 2002-12-20 EP EP02806511A patent/EP1458357B1/en not_active Expired - Lifetime
- 2002-12-20 AU AU2002367032A patent/AU2002367032B8/en not_active Ceased
- 2002-12-20 DE DE60231428T patent/DE60231428D1/de not_active Expired - Lifetime
- 2002-12-20 JP JP2003559480A patent/JP4959919B2/ja not_active Expired - Fee Related
- 2002-12-20 WO PCT/US2002/041299 patent/WO2003059317A2/en not_active Ceased
- 2002-12-20 AT AT02806511T patent/ATE424186T1/de not_active IP Right Cessation
- 2002-12-20 US US10/327,200 patent/US7718162B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006502086A5 (https=) | ||
| Mimoto et al. | Kynostatin (KNI)-227 and-272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine | |
| JP4990155B2 (ja) | プロテアソームを阻害するための組成物 | |
| JP3731899B2 (ja) | 酸化窒素放出生体高分子含有医薬組成物 | |
| RU2191189C2 (ru) | Производные замещенного пуринила, обладающие иммуномодуляторной активностью, фармацевтическая композиция и способ замедления роста опухоли | |
| JP5537431B2 (ja) | ウイルス融合のインヒビターのコレステロール誘導体 | |
| JPH05505824A (ja) | 所定投与量エアロゾル製剤の製造のための可溶性弗素界面活性剤の使用 | |
| WO2017211917A1 (fr) | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide statistique | |
| ES2373561T3 (es) | Uso de derivados de 1,4-bis(3-aminoalquil)piperazina en el tratamiento de enfermedades neurodegenerativas. | |
| WO2019110838A1 (fr) | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide | |
| KR20120125610A (ko) | 시클로스포린 유사체 | |
| Sohma et al. | Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage | |
| JP2005514440A5 (https=) | ||
| Robles et al. | Solid-phase synthesis of a nucleopeptide from the linking site of adenovirus-2 nucleoprotein,-Ser (p 5′ CATCAT)-Gly-Asp-. Convergent versus stepwise strategy | |
| WO2013029182A1 (en) | Stable peptide-based furin inhibitors | |
| EP4166133A1 (en) | Composition containing peptide compound and surfactant | |
| DK149091C (da) | Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf | |
| AU2008339610B2 (en) | Methods of peptide modification | |
| ES2361921T3 (es) | Inhibidores duales antitrombóticos que comprenden un residuo de biotina. | |
| ATE402949T1 (de) | Dipeptidtransglutaminaseinhibitoren und verfahren zu deren anwendung | |
| RU2003121303A (ru) | Композиции, содержащие аддукты | |
| CS201013B2 (en) | Process for preparing new analoges of angiotensine | |
| KR870000360A (ko) | 바조프레신 길항근 | |
| CN102731626B (zh) | 环肽及其医药用途 | |
| Das et al. | Molecular design and structure–activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664 |